Foghorn Therapeutics Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 2.09 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 124.12M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing therapies for mutant; non-small cell lung; endometrial, cervical, ovarian, and bladder cancer; and diffuse large B-cell lymphoma, as well as various acute myeloid leukemia and myelodysplastic syndrome. The company has collaboration agreement with Eli Lilly and Company for developing FHD-909, a selective ATPase inhibitor of BRM. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
Details
| Name | Foghorn Therapeutics Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 106 |
| Founded | 2015 |
| Ipo Date | 2020-10-23 |
| Ceo | Adrian H. Gottschalk |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 16.00 |
| Isin | US3441741077 |
| Cusip | 344174107 |
| Cik | 0001822462 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Karin Hellsvik | Chief of Staff to the Chief Executive Officer, Vice President, Head of Corporate Affairs, Investor Relations and Operations |
| Adrian H. B. Gottschalk | President, Chief Executive Officer and Director |
| Dr. Douglas G. Cole M.D. | Founder and Independent Chairman of the Board |
| Dr. Steven F. Bellon Ph.D. | Chief Scientific Officer |
| Dr. Alfonso Quintas Cardama M.D. | Chief Medical Officer |
| Dr. Gerald R. Crabtree M.d. | Founder and Member of Scientific Advisory Board |
| Ryan D. Maynard | Chief Financial Officer |
| Michael J. LaCascia J.D. | Chief Legal Officer |
| Saurabh Sewak Ph.D. | Vice President of Corporate Development |
| Carlos Costa | Chief People Officer |
Contact
| Address | 99 Coolidge Avenue, Suite 500, Watertown, Massachusetts 02472, United States |
| Phone | 617 586 3100 |
| Website | https://foghorntx.com |